Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1997 Jan;175(1):57-62.
doi: 10.1093/infdis/175.1.57.

Genital shedding of human immunodeficiency virus type 1 DNA during pregnancy: association with immunosuppression, abnormal cervical or vaginal discharge, and severe vitamin A deficiency

G C John  1 , R W Nduati, D Mbori-Ngacha, J Overbaugh, M Welch, B A Richardson, J Ndinya-Achola, J Bwayo, J Krieger, F Onyango, J K Kreiss
Affiliations

Genital shedding of human immunodeficiency virus type 1 DNA during pregnancy: association with immunosuppression, abnormal cervical or vaginal discharge, and severe vitamin A deficiency

G C John et al. J Infect Dis. 1997 Jan.

Abstract

The presence of human immunodeficiency virus type 1 (HIV-1) in genital secretions may be a determinant of vertical HIV-1 transmission. Cervical and vaginal secretions from HIV-1-seropositive pregnant women were evaluated to determine prevalence and correlates of HIV-1-infected cells in the genital tract. HIV-1 DNA was detected by polymerase chain reaction in 32% of 212 cervical and 10% of 215 vaginal specimens. Presence of HIV-1 DNA in the cervix was associated with cervical mucopus and a significantly lower absolute CD4 cell count (354 vs. 469, P < .001). An absolute CD4 cell count <200 was associated with a 9.6-fold increased odds of cervical HIV-1 DNA detection compared with a count > or = 500 (95% confidence interval, 2.8-34.2). Detection of vaginal HIV- 1 DNA was associated with abnormal vaginal discharge, lower absolute CD4 cell count, and severe vitamin A deficiency. Presence of HIV-1-infected cells in genital secretions was associated with immunosuppression and abnormal cervical or vaginal discharge.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Prevalence of cervical HIV-1 DNA by absolute CD4 cell count. OR = odds ratio.
See this image and copyright information in PMC

References

    1. WHO/GPA/CNP/EVA/93.1. Geneva: WHO; 1993. Global program on AIDS.
    1. Mofenson LM. Epidemiology and determinants of vertical HIV transmission. Semin Pediatr Infect Dis. 1994;5:253–265.
    1. Connor EM, Sperling RS, Gelber R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type-1 with zidovudine treatment. N Engl J Med. 1994;331:1173–1180. - PubMed
    1. Boyer PJ, Dillon M, Navaie M, et al. Factors predictive of maternal-fetal transmission of HIV-1. Preliminary analysis of zidovudine given during pregnancy and/or delivery. JAMA. 1994;271:1925–1930. - PubMed
    1. European Collaborative Study. Risk factors for mother-to-child transmission of HIV-1. Lancet. 1992;339:1007–1012. - PubMed

Publication types

MeSH terms